(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies.
Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticoagulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).
Contents:
Part 1: Basic Principles
Chapter 1 The Platelet in Arterial and Venous Thrombosis
Peter Kelly, MD
Edward F. Plow, PhD
Chapter 2 The Coagulation Cascade in Arterial and Venous Thrombosis
Kandice Marchant, MD, PhD
Chapter 3 The Link Between Thrombosis and Inflammation
John H. Cleator, MD
Mark Robbins, MD
Chapter 4 Genetics of Thrombosis
Svati H. Shah, MD, MHS
Richard C. Becker, MD
Part II: Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease
Chapter 5 Aspirin for Primary and Secondary Prevention
Jinesh Kochar, MD, MPH
J, Michael Gaziano, MD, MPH
Chapter 6 Thienopyridines in Stable CAD Patients
Dipak Kotecha, MBChB., MRCP.
Marcus D. Flather, MBBS, FRCP
Part III: Antithrombotic Therapy for NSTE ACS
Chapter 7 Anti-platelet Therapies: Aspirin, Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors
Saif Anwaruddin MD
Deepak L. Bhatt MD
Chapter 8 Unfractionated Heparin and Enoxaparin
Pierluigi Tricoci, MD, MHS, PhD
Kenneth W. Mahaffey, MD
Chapter 9 The Direct Thrombin Ihibitors
Tyler Taigen, MD
James Harvey, MD
A. Michael Lincoff, MD
Chapter 10 Synthetic Factor Xa Inhibition, Fondaparinux
Michael S. Kim, MD
Robert L. Page, Pharm.D
Ivan P. Casserly, MBBCh
Part IV: Antithrombotic Therapy for STEMI
Chapter 11 Antiplatelet Therapies: Aspirin,Clopidogrel and thienopyridines and Glycoprotien IIb/IIIa Inhibitors
Rory B. Weiner, MD
Marc S. Sabatine, MD, MPH
Chapter 12 Antithrombin Therapies: Unfractionated Heparin, Enoxaparin, Direct Thrombin Inhibitors, Fondaparinux
John M. Galla, MD
Arman T. Askari, MD
Chapter 13 Fibrinolysis and Facilitated PCI
RyanD. Christofferson, MD
Sorin J. Brener, MD
Part V: Antithrombotic Therapy in Interventional Cardiology
Chapter 14 Antithrombotic Therapy in Percutaneous Coronary Intervention
Adrian W. Messerli, MD
Chapter 15 Antithrombotic Therapy in Carotid and Peripheral Intervention
Thomas J. Helton, MD
Samir R. Kapadia, MD
Chapter 16 Monitoring of Antithrombotic Therapies
Kristofer Dosh, MD
Steven Steinhubl, MD
Part VI: Antithrombotic Therapy in Venous Thromboembolic Disease
Chapter 17 Antithrombotic Therapy for DVT/PE
Esther S.H. Kim, MD
John R. Bartholomew, MD
Chapter 18 Fibrinolysis for PE
Stavros V. Konstantinides, MD
Chapter 19 Duration of Anticoagulation Following VTE
Clive Kearon, MB MRCPI FRCPC PhD
Part VII: Clinical Considerations
Chapter 20 Antithrombotic Therapy for Atrial Fibrillation
Carmel M. Halley MD
Allan L. Klein MD
Chapter 21 Antithrombotic Therapy for Valvular Heart Disease
Noah Rosenthal MD
Brian D. Hoit MD
Chapter 22 Antithrombotic Therapy for Cardiomyopathy
Zuheir Abrahams MD PhD
George Sokos MD
W. H. Wilson Tang MD
Chapter 23 Heparin-Induced Thrombocytopenia
John R. Bartholomew, MD
Chapter 24 'Resistance' to Antiplatelet Therapies
Gerald C. Koenig, MD, PhD
Hitinder S. Gurm, MD
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2009
Pages: 490
Weight: 1360g
Availability: Available
Subcategories: Cardiovascular Medicine, Diseases and Disorders, Radiology, Vascular
Publisher recommends
From the same series
